Xponance’s PRA Health Sciences, Inc. PRAH Stock Holding History

Xponance’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,554	Closed	-$2.24M	–	1262
2021 Q2	$2.24M	Buy	13,554 +1,190	+10%	+$199K	0.04%	344
2021 Q1	$1.9M	Hold	12,364	–	–	0.04%	324
2020 Q4	$1.55M	Buy	12,364 +75	+0.6%	+$8.39K	0.03%	358
2020 Q3	$1.25M	Buy	12,289 +942	+8%	+$96K	0.03%	371
2020 Q2	$1.1M	Buy	+11,347	New	+$1.06M	0.03%	365

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Xponance's PRAH Position: Q3 2021 in Review

Xponance sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 13,554 shares — an estimated $2.24M sold.

Xponance first reported a position in PRAH in Q2 2020 and held it in 5 quarters. The position peaked at $2.24M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Xponance reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Xponance sold 13,554 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $2.24M.
Xponance first reported a position in PRA Health Sciences, Inc. in Q2 2020 and held it in 5 quarters.
Xponance's PRA Health Sciences, Inc. position peaked at $2.24M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Xponance's 13F filing for Q3 2021, filed 5 Nov 2021.